Clinical trial
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for…
NCT00148148 · University Hospital Muenster, Other · Completed
Key facts
| NCT number | NCT00148148 |
|---|---|
| Title | A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation |
| Official title | Phase II Randomised Study of the Safety, Efficacy and Pharmacokinetics of Caspofungin (CAS), Liposomal Amphotericin B (LAMB) or the Combination of Caspofungin With Liposomal Amphotericin B for Patients After Stem-Cell Transplantation |
| Lead sponsor | University Hospital Muenster, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry Gilead Sciences |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hematopoietic Stem Cell Transplantation, Fungus Diseases |
| Intervention type | Drug |
| Interventions | caspofungin, liposomal amphotericin B |
| Enrollment | 75 |
| Start date | May 1, 2004 |
| Completion | Dec 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Jan 16, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: